Akt Deficiency Attenuates Muscle Size and Function but Not the Response to ActRIIB Inhibition
Open Access
- 15 September 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (9), e12707
- https://doi.org/10.1371/journal.pone.0012707
Abstract
Akt is a critical mediator of developmental skeletal muscle growth. Treatment with a soluble ActRIIB fusion protein (ActRIIB-mFc) increases skeletal muscle mass and strength by inhibiting myostatin and related peptides. Recent in vitro studies have suggested that Akt signaling is necessary for the ability of ActRIIB inhibition to induce muscle hypertrophy. Thus, we hypothesized that mice deficient in either Akt1 or Akt2 would not respond to in vivo inhibition of ActRIIB with ActRIIB-mFc treatment. We analyzed body composition and muscle parameters in wild-type C57BL/6J and Akt1 and Akt2 knockout mice, and compared the responses to blockade of ActRIIB signaling via ActRIIB-mFc treatment. Mice lacking Akt1 or Akt2 had reduced muscle mass, grip strength and contractile force. However, deficiency of Akt1 or Akt2 did not prevent the ability of ActRIIB-mFc treatment to induce muscle hypertrophy, or increase grip strength and contractile force. Akt1 and Akt2 deficient mice responded similarly as wild type mice to ActRIIB-mFc treatment by increasing fiber size. Akt1 and Akt2 are important for the regulation of skeletal muscle mass and function. However, these Akt isoforms are not essential for the ability of ActRIIB inhibition to regulate muscle size, fiber type, strength or contractile force.Keywords
This publication has 41 references indexed in Scilit:
- Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber typeJournal of Applied Physiology, 2010
- Pretreatment with a soluble activin type IIB receptor/Fc fusion protein improves hypoxia-induced muscle dysfunctionAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2010
- Myostatin inhibits IGF-I-induced myotube hypertrophy through AktAmerican Journal of Physiology-Cell Physiology, 2009
- The effects of a soluble activin type IIB receptor on obesity and insulin sensitivityInternational Journal of Obesity, 2009
- Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube sizeAmerican Journal of Physiology-Cell Physiology, 2009
- Inhibition of ADRP prevents diet-induced insulin resistanceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Myostatin induces p300 degradation to silence cyclin D1 expression through the PI3K/PTEN/Akt pathwayCellular Signalling, 2008
- Fast/Glycolytic Muscle Fiber Growth Reduces Fat Mass and Improves Metabolic Parameters in Obese MiceCell Metabolism, 2008
- mTOR is the rapamycin‐sensitive kinase that confers mechanically‐induced phosphorylation of the hydrophobic motif site Thr(389) in p70S6kFEBS Letters, 2007
- Quadrupling Muscle Mass in Mice by Targeting TGF-ß Signaling PathwaysPLOS ONE, 2007